Lacosamida Dr. Reddys 10 mg/ml Infusion Solution
Read this leaflet carefully before you start using this medicine because it contains important information for you.
What is Lacosamida Dr. Reddys
Lacosamida Dr. Reddys contains lacosamida, which belongs to a group of medicines called “antiepileptic medicines”. These medicines are used to treat epilepsy.
Do not use lacosamida if any of the above applies to you. If you are unsure, consult your doctor or pharmacist before starting to use this medication.
Consult your doctor before starting to use lacosamida if:
If any of the above applies to you (or you are unsure), consult your doctor or pharmacist before starting to use lacosamida.
If you are taking lacosamida, consult your doctor if you experience a new type of seizure or worsening of existing seizures.
If you are taking lacosamida and experience symptoms of abnormal heart rhythm (such as slow, fast, or irregular heartbeat, palpitations, shortness of breath, dizziness, fainting), consult your doctor immediately (see section 4).
Lacosamida is not recommended for children under 2 years with epilepsy characterized by the onset of partial seizures and is not recommended for children under 4 years with primary generalized tonic-clonic seizures. This is because it is not yet known if it is effective and safe for children in this age group.
Inform your doctor or pharmacist if you are using or have used recently or may need to use any other medication.
In particular, inform your doctor or pharmacist if you are taking any of the following medications that affect the heart, as lacosamida may also affect the heart:
If any of the above applies to you (or you are unsure), speak with your doctor or pharmacist before starting to use lacosamida.
Also inform your doctor or pharmacist if you are using any of the following medications, as they may also increase or decrease the effect of Lacosamida Dr. Reddys on your body:
If any of the above applies to you (or you are unsure), speak with your doctor or pharmacist before starting to use Lacosamida Dr. Reddys.
As a precaution, do not use Lacosamida Dr. Reddys with alcohol.
Women of childbearing age should discuss the use of contraceptives with their doctor.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
Lacosamida is not recommended during pregnancy, as its effects on pregnancy and the fetus are unknown. It is also not recommended to breastfeed while taking lacosamida, as lacosamida passes into breast milk.
Seek advice immediately from your doctor if you are pregnant or plan to become pregnant. They will help you decide if you should take lacosamida or not.
Do not stop treatment without first talking to your doctor, as this may increase seizures (crises). A worsening of your condition may also harm the fetus.
You should not drive, cycle, or use machines until you know if this medication affects you. The reason is that lacosamida may cause dizziness or blurred vision.
This medication contains 59.8 mg of sodium (main component of table salt/for cooking) in each vial. This is equivalent to 3% of the recommended daily maximum sodium intake for an adult. You should be aware of this if you are on a controlled sodium diet.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
When you switch from infusion to taking the medication orally (or vice versa), the total amount you take each day and the frequency with which you take it remain the same.
•Use lacosamida twice a day (with approximately 12 hours of difference).
•Try to use it approximately at the same time every day.
The following are the normal recommended doses of Lacosamida Dr. Reddys for different age groups and weights. Your doctor may prescribe a different dose if you have kidney or liver problems.
When using lacosamida alone:
Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 300 mg twice a day.
When using lacosamida with other antiepileptic medications:
When using lacosamida alone
To be used twice a day,for children aged 2 years or olderweighing from 10 kg to less than 40 kg
Weight | Week 1 Starting dose: 0.1 ml/kg | Week 2 0.2 ml/kg | Week 3 0.3 ml/kg | Week 4 0.4 ml/kg | Week 5 0.5 ml/kg | Week 6 Maximum recommended dose: 0.6 ml/kg |
10 kg | 1 ml | 2 ml | 3 ml | 4 ml | 5 ml | 6 ml |
15 kg | 1.5 ml | 3 ml | 4.5 ml | 6 ml | 7.5 ml | 9 ml |
20 kg | 2 ml | 4 ml | 6 ml | 8 ml | 10 ml | 12 ml |
25 kg | 2.5 ml | 5 ml | 7.5 ml | 10 ml | 12.5 ml | 15 ml |
30 kg | 3 ml | 6 ml | 9 ml | 12 ml | 15 ml | 18 ml |
35 kg | 3.5 ml | 7 ml | 10.5 ml | 14 ml | 17.5 ml | 21 ml |
To be used twice a day,for adolescents and childrenweighing from 40 kg to less than 50 kg:
Weight | Week 1 Starting dose: 0.1 ml/kg | Week 2 0.2 ml/kg | Week 3 0.3 ml/kg | Week 4 0.4 ml/kg | Week 5 Maximum recommended dose: 0.5 ml/kg |
40 kg | 4 ml | 8 ml | 12 ml | 16 ml | 20 ml |
45 kg | 4.5 ml | 9 ml | 13.5 ml | 18 ml | 22.5 ml |
When using lacosamida with other antiepileptic medications
To be used twice a day,for children aged 2 years or olderweighing from 10 kg to less than20 kg
Weight | Week 1 Starting dose: 0.1 ml/kg | Week 2 0.2 ml/kg | Week 3 0.3 ml/kg | Week 4 0.4 ml/kg | Week 5 0.5 ml/kg | Week 6 Maximum recommended dose: 0.6 ml/kg |
10 kg | 1 ml | 2 ml | 3 ml | 4 ml | 5 ml | 6 ml |
15 kg | 1.5 ml | 3 ml | 4.5 ml | 6 ml | 7.5 ml | 9 ml |
To be used twice a day,for adolescents and childrenweighing from 20 kg to less than 30 kg:
Weight | Week 1 Starting dose: 0.1 ml/kg | Week 2 0.2 ml/kg | Week 3 0.3 ml/kg | Week 4 Maximum recommended dose: 0.4 ml/kg |
20 kg | 2 ml | 4 ml | 6 ml | 8 ml |
25 kg | 2.5 ml | 5 ml | 7.5 ml | 10 ml |
To be used twice a day,for adolescents and childrenweighing from 30 kg to less than 50 kg
Weight | Week 1 Starting dose: 0.1 ml/kg | Week 2 0.2 ml/kg | Week 3 0.3 ml/kg | Week 4 Maximum recommended dose: 0.4 ml/kg |
30 kg | 3 ml | 6 ml | 9 ml | 12 ml |
35 kg | 3.5 ml | 7 ml | 10.5 ml | 14 ml |
40 kg | 4 ml | 8 ml | 12 ml | 16 ml |
45 kg | 4.5 ml | 9 ml | 13.5 ml | 18 ml |
If your doctor decides to stop your treatment with lacosamida, they will gradually reduce your dose. This is to prevent seizures from recurring or worsening.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The side effects in the nervous system, such as dizziness, may be more pronounced after a single "loading" dose.
Inform your doctor or pharmacist if you experience any of the following side effects: Very common: may affect more than 1 in 10 patients
Common: may affect up to 1 in 10 patients
Uncommon: may affect up to 1 in 100 patients
Frequency not known: cannot be estimated from available data
Local adverse reactions may occur.
Common: may affect up to 1 in 10 patients
Uncommon: may affect up to 1 in 100 patients
Additional adverse effects observed in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), eating less than usual (decreased appetite), changes in behavior, not acting normally (abnormal behavior), and lack of energy (lethargy). Drowsiness (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and vial after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conservation conditions.
Each vial of Lacosamida Dr. Reddys infusion solution must be used only once (single use). Unused solution must be discarded.
Only clear solutions, free of particles and without color change should be used.
Medications should not be thrown down the drain or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. This will help protect the environment.
Lacosamide Dr. Reddy’s Composition
1 ml of Lacosamide Dr. Reddy’s infusion solution contains 10 mg of lacosamide.
1 vial contains 20 ml of Lacosamide Dr. Reddy’s infusion solution, equivalent to 200 mg of lacosamide.
Lacosamide Dr. Reddy’s infusion solution is available in packages with 1 vial and 5 vials. Each vial contains 20 ml.
Only some package sizes may be marketed.
Marketing Authorization Holder
Reddy Pharma Iberia, S.A.
Avda. Josep Tarradellas nº 38
08029 Barcelona
Spain
Responsible for manufacturing
betapharm Arzneimittel GmbH
Kobelweg 95
86156 Augsburg
Germany
or
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park
Paola PLA 3000
Malta
or
Rual Laboratories SRL
313, Splaiul Unirii, Building H 1st floor, sector 3
Bucuresti, 030138
Romania
This medicine is authorized in the member states of the European Economic Area with the following names:
Member state name | Medicine name |
Spain | Lacosamida Dr. Reddys 10 mg/ml infusion solution EFG |
Italy | Lacosamide Dr. Reddy’s |
Last review date of this leaflet:January 2024
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
This information is intended solely for doctors or healthcare professionals:
Each vial of Lacosamide Dr. Reddys infusion solution should be used only once (single use). The unused solution should be discarded (see section 3).
Lacosamide Dr. Reddys infusion solution can be administered without additional dilution, or it can be diluted with the following solutions: sodium chloride 9 mg/ml (0.9%), glucose 50 mg/ml (5%) or Ringer Lactate solution.
From a microbiological point of view, the medicine should be used immediately. If not used immediately, the storage times in use and the conditions prior to use are the responsibility of the user and should not be greater than 24 hours at a temperature of between 2 and 8 °C, unless the dilution has taken place in validated and controlled conditions and in an aseptic environment.
The chemical and physical stability in use has been demonstrated for 24 hours at temperatures up to 25 °C for medicines mixed with these diluents and stored in glass or PVC bags.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.